IGC Pharma, Inc. (IGC) News
Follow IGC Pharma, Inc. (IGC) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 7 public stories across 7 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
IGC Pharma Reports Third-Quarter 2026 Results and Business Update
The company says CALMA randomized 170 participants; topline results are expected after last patient-last dose, database lock and unblinding.
EQUITY | Nov 09, 2026, 01:06 PM UTC
L
IGC raises 2026/27 world corn crop forecast
LONDON, Oct 15 (Reuters) — The International Grains Council has raised its forecast for 2026/27 global corn production by 6 million metric tons to 1.307 billion tons, it said on Thursday. In its monthly update, the inter
NEWS | Oct 15, 2026, 12:37 PM UTC
L
IGC Pharma Completes Enrollment in Phase 2 CALMA Alzheimer's Trial; Topline Results Expected Q4 2026
POTOMAC, MD / / September 28, 2026 / IGC Pharma, Inc. AMEX:IGC ("IGC" or the "Company") today announced it has completed enrollment in its CALMA Phase 2 trial evaluating lead asset, IGC-AD1, for agitation in Alzheimer's
NEWS | Sep 28, 2026, 12:08 PM UTC
L
India Capital Growth Fund Reports Nav Total Return 3.1% For Six Months Ended 30 June
India Capital Growth Fund Ltd LSE:IGC
NEWS | Sep 24, 2026, 06:22 AM UTC
L
IGC Pharma reports Q2 2026 results; CALMA enrollment nears closure
IGC Pharma reports Q2 2026 results and says its CALMA Alzheimer’s trial moves within six randomizations of enrollment closure.
EARNINGS | Aug 17, 2026, 12:30 PM UTC
M
IGC Evaluates Recovery Options
IGC explores recovery options
EQUITY | Jul 29, 2026, 12:30 PM UTC
M
IGC Reduces Alzheimer's Data Time
IGC Pharma's AHA Agentic AI Platform reduces Alzheimer's data harmonization time by 90% in a representative workflow
EQUITY | Jun 23, 2026, 12:31 PM UTC